BWNB Babcock 2026 Q4 2025 earnings outperform forecasts as EPS turns positive against projected quarterly loss Biogen Inc BIIB Structural Headwinds Justify Avoidance Despite Current Profitability OLB The OLB rises 23 percent after Q4 2025 earnings outpace consensus analyst EPS estimates